Loading company…
Nanospectra Biosciences, founded in 2002 in Houston, US, makes the AuroLase Therapy System for laser-based cancer treatment using gold nanoshells.
Founded in 2002 and headquartered in Houston, US, Nanospectra Biosciences is a medical technology company focused on cancer treatment. Its AuroLase Therapy System uses gold nanoshells and laser-induced thermal therapy to destroy tumors, aiming to reduce damage to surrounding healthy tissue. Hospitals and cancer treatment centers in North America and parts of Europe are its main customers. In September 2020, the company raised USD 3.000 mn in a Series B round led by Sirtex Medical Limited, and it has raised USD 3.000 mn in total.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in